#TSP TruSpine Technologies PLC – Convertible Loan Note Conversion & Issue of Equity June 5, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that, further to the announcement on 26 March 2024, the Company has elected to convert the Lender CLN Subscription of £200,000 into 13,333,333 new ordinary shares at a price of 1.5 pence per share (“CLN Shares”) pursuant to the terms of the CLN Instrument.   Admission   Application has been made for the CLN Shares to be admitted to trading…

Continue reading

#TSP TruSpine Technologies PLC – Convertible Loan Note, Debenture and AGM Update March 28, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, provides an update in relation (1) unsecured Convertible Loan Note instrument announced on 14 March 2024, (2) the Debenture announced on 27 February 2023 and (3) the 2023 Annual General Meeting (“2023 AGM”).   Convertible Loan Note   As announced on 14 March 2024, the Company constituted an unsecured Convertible Loan Note instrument for the issue of loan notes (“CLN” or…

Continue reading